
Biotechnology • Healthcare Insurance • Pharmaceuticals
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health. Our technology includes both our recombinant protein-based nanoparticle and Matrix-M™ adjuvant, which we use to accelerate the development of innovative vaccines against serious infectious diseases. We aim to maximize the impact of our cutting-edge technology and address areas of unmet need in global health.
October 14
Director of Intellectual Property managing patent protection strategies for Novavax in global markets. Collaborating across teams to direct outside counsel and support IP-related transactions.